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Case report
 A 14-year-old phenotypic female was referred to our 
hospital with primary amenorrhea and delayed pubertal 
development. She was 172 cm tall (above the 95th percen-
tile) and weighed 88.5 kg (above the 95th percentile); her 
BMI was 29.9 kg/m2 (growth above the genetic target and 
the normal female population). The patient, born at term 
by spontaneous delivery, reported repeated episodes of  
narcolepsy and lipothymia during physical activities and a 
single episode of  plausible vaginal bleeding at 10 years. A 
physical exam revealed Tanner stage B3P2, with little pubic 
and axillary hair. The pelvic exam demonstrated hypoplas-
tic labia majora, a blind-ended vagina, and the absence of  
uterus and cervix. Laboratory tests showed typical hormo-
nal changes for age, sex, and pubertal stage: high testoster-
one (26.3 ng/dl), DHEAS (205.9 µg/dl), and LH (121 
mUI/ml), with low FSH (12 mUI/ml) and normal estra-
diol (16 pg/ml); the karyotype analysis was 46,XY. 
A transabdominal ultrasonography exam of  the pelvis, 
performed in another hospital, demonstrated the absence 
of  the uterus and gonadal structures. MRI (Achieva®, Phil-
ips Medical System, Eindhoven, the Netherlands, 1.5 T) 
was performed with axial T1W, axial and sagittal T2W 
turbo spin echo HR (high resolution), and coronal STIR 
TSE and axial diffusion-weighted imaging (DWI) (b values: 
0 and 1000 s/mm2) sequences. Conventional sequences 
demonstrated two homogeneous ovoid solid masses, hy-
pointense on T1 and iso-hyperintense on T2, in the ingui-
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nal canal close to the external ring, consistent with testes 
(Fig. 1, A-B). The right gonad measured 1.8x1.9x3.1 cm, 
and the left measured 1.7x2.4x2.9 cm. Tubular, subtle, T2-
hyperintense structures, adjacent to the gonads, were seen; 
they appeared to be similar in size and shape to atrophic 
epididymides (Fig. 1C). There was no evidence  of  the 
uterus in the pelvis; sagittal T2W TSE demonstrated the 
presence of  a short, blind-ended vagina between the blad-
der and (posteriorly) the rectum. In the recto-uterine 
pouch, there was free fluid collection (Fig. 2). DWI 
(b=1000) showed hyperintense extrapelvic gonads due to 
restricted diffusion, and low values on the ADC map (0.8 
mm2/s on the right and 0.9 mm2/s on the left) (Fig. 3). The 
patient subsequently underwent hormonal replacement 
therapy and received psychosocial support.
Commonly included in the differential diagnosis are 
other causes of  primary amenorrhea, in particular the 
Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, 
characterized by Müllerian duct anomalies (congenital ab-
sence of  the upper part of  the vagina, uterine agenesis, or 
the presence of  a rudimentary 
uterus), a female karyotype, nor-
mal female external genitalia, 
normal breast development, and 
normal axillary and pubic hair. In 
Swyer syndrome (or 46,XY com-
plete gonadal dysgenesis), the pa-
tient presents with normal female 
external genitalia, lack of  breast 
development, and short stature 
with completely undeveloped 
(“streak”) gonads and the presence 
of  Müllerian structures. Partial 
androgen insensitivity syndrome 
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Fig. 2. Sagittal T2 TSE shows a blind-ended vagina (white 
arrow) between the bladder and the rectum posteriorly and 
the absence of Müllerian structures, such as the uterus; a 
fluid collection fills the Douglas pouch (white arrowhead).
Fig. 1. (A-B) Axial T1- and T2-weighted images reveal bilateral solid nodular structures with homogeneous, 
mild hyperintensity in the anterior lower pelvic wall, adjacent to the external inguinal ring, compatible with tes-
tes (black arrow); (C) Sagittal T2 TSE image shows subtle, hyperintense, tubular structure similar to atrophic 
epididymides behind the gonads (black arrow).
Fig. 3. DWI demonstrates hyperintense signal of the extrapelvic gonads; ADC map 
shows bilateral low signal intensity with 0.8 mm2/s  on the right and 0.9 mm2/s on the 
left. No signs of malignant degeneration are detected.
(PAIS) differs from CAIS because of  the presence of  a mi-
crophallus or bifid scrotum with descended or undescended 
testes; in mild androgen insensitivity syndrome (MAIS), 
there is impaired spermatogenesis in the absence of  male 
genital anomalies.
Discussion
CAIS is one of  the most frequent disorders of  sex devel-
opment (DSD), described for the first time in 1953 by John 
Morris (1), an American gynecologist, and called “testicular 
feminization syndrome” (supposing that the testicles of  
these patients could produce estrogenic hormones with a 
feminizing effect on the body). CAIS is a rare, recessive X-
linked disorder caused by mutations of  the androgen recep-
tor (AR), in which genetic males (46,XY) show phenotypic 
female external genitalia. The estimated prevalence is be-
tween 1/20,000 and 1/65,000 or 1-5/100,000 genetic 
males. More than 1,000 different AR mutations have been 
reported, in particular on the proximal long arm of  the X 
chromosome (Xq11-12) (2). According to the typology of  
AR mutations, the sexual development disorder can be 
complete (CAIS), partial (PAIS), or mild (MAIS). 
CAIS can be detected by chance during the first few days  
of  life as a result of  a discrepancy between the prenatal sex 
prediction and the phenotype at birth, or in the case of  
monolateral or bilateral inguinal hernia in a young girl con-
taining testes, or in the case of  a pelvic tumor in adults. 
Mostly, CAIS patients remain unrecognized until puberty, 
when they present with primary amenorrhea. Typically, 
patients with CAIS have a male karyotype and, despite 
normal testicular production of  testosterone and dihydro-
testosterone, do not develop male genitalia or male secon-
dary sexual characteristics due to the androgen-receptor-
impaired function. In these patients, the Woffian duct (an-
drogen dependent) does not develop into the epididymis, 
the vas deferens, and the seminal vesicles. Also, due to the 
production of  Müllerian-inhibiting factor (MIF) by testicu-
lar Sertoli cells, the Müllerian duct does not develop fallo-
pian tubes, uterus, and two-thirds of  the proximal vagina. 
The testes can be located in the inguinal canal, intra-
abdominal or labial; quite commonly, they are close to 
small cystic structures considered remnants of  the Mülle-
rian or Wolffian ducts. CAIS individuals typically show a 
female gender identity, breast development consistent with 
age (for the peripheral aromatization of  testosterone), little 
pubic and axillary hair, primary amenorrhea, and a short, 
blind-ended vagina. Actually, only 35% of  the patients 
demonstrate vaginal hypoplasia at physical examination 
and require vaginal dilatation or surgical reconstruction.
CAIS patients are usually taller than the normal female 
population but shorter than males and have a decreased 
bone mineral density before and after gonadectomy that 
can be corrected by estrogen replacement therapy and cal-
cium or vitamin D supplements. CAIS women do not seem 
to have an increased risk of  fractures (3).
Serum testosterone levels are within or above the normal 
range for males, and luteinizing hormone (LH) and estra-
diol concentrations are higher than in males but lower than 
in females without CAIS, due to the androgen insensitivity 
and the lack of  negative feedback on the hypothalamic-
pituitary axis (4). 
The intra-abdominal position of  the testes is a well-
known predisposing condition to gonadal tumors: prepu-
bertal tumors are rare, with an incidence of  0.8% in CAIS 
patients due to normal and not dysgenetic testes, while in 
adults, the risk increases to 14% (5).
Traditional management of  CAIS includes early 
gonadectomy in infancy and puberty induction with subse-
quent hormonal replacement therapy, or delayed gonadec-
tomy in late adolescence after completion of  puberty. The 
timing of  gonadectomy is becoming controversial, and 
many women prefer to delay or deny the surgical proce-
dure for a variety of  reasons including psychological fac-
tors, surgical risk, preservation of  fertility potential, and 
refusal of  lifelong therapy (6).
Imaging examinations play a pivotal role in the diagno-
sis, assessment, and detection of  the gonads before surgical 
treatments. Transabdominal ultrasonography (US) repre-
sents the first-line examination in evaluating the absence of 
Müllerian structures and the location of  the testes, with a 
high sensitivity at the level of  the inguinal canal.
MRI is the gold standard for diagnosis and localization 
of  the gonads and for the evaluation of  Müllerian abnor-
malities (accuracy, 100%) due to detailed anatomic infor-
mation, superior tissue characterization, and multiplanar 
capability. In particular, MRI has higher sensitivity than 
US for the intra-abdominal and pelvic localization of  the 
gonads.
MRI plays a key role in the planning of  laparoscopic 
gonadectomy and seems to be useful in the gonadic surveil-
lance ("watchful waiting") in the increasingly large number 
of  patients who decide to delay or not undergo gonadec-
tomy (7). Conventional axial and sagittal T1 and T2 se-
quences can demonstrate the absence of  the uterus, the 
length of  the vagina, and the presence and location of  the 
testes; they also help to show gonadic malignant 
degeneration. Normal testes appear hypointense on T1 
sequences and homogeneously hyperintense on T2 se-
quences; malignant degeneration can appear as low signal 
intensity foci with the disappearance of  the testicular 
septa (8).
Individuals with CAIS have testes that differ from 
healthy males in terms of  size, location, and signal intensity, 
and they are more similar to retained testes in tems of  
morphology and signal intensity due to atrophy and fibro-
sis. Several reports demonstrate the presence of  immature 
and atrophic seminiferous tubules and fibrotic stroma when  
these testes undergo histologic examination (2, 9). Atrophy 
and fibrosis would be directly involved in the reduction of  
the testes' mean volume in CAIS patients (9.2cm3) com-
pared to average testicular volume in a European man (18 
cm3; range, 12-30 cm3). Common findings at MRI of  testes 
in patients with CAIS are cystic structures, as benign parat-
esticular simple cysts or serous gonadal cysts, and Sertoli 
cell adenomas that can mimic malignant germ-cell 
tumors (10).
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Furthermore, in our case, we perform an axial DWI (b 
values: 0 and 1000 s/mm2) sequence that shows a homoge-
neous hyperintense signal of  the gonads, with a mean ADC 
value ranging from 0.8 to 0.9 mm2/s and with no evidence 
of  focal areas of  altered signal. Due to the lack of  specific-
ity of  tumoral markers, it seems crucial to find screening 
and diagnostic tools for early identification of  gonadic, ma-
lignant lesions. DWI, as a complementary sequence, could 
contribute to early detection of  malignant lesions and could 
be helpful in monitoring retained testes in CAIS patients. 
In conclusion, MRI is a useful technique to assess 
gonadectomy and to monitor patients who refuse or delay 
surgical treatment.
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